Cadila Healthcare Limited has informed the Exchange regarding a press release dated January 23, 2021, titled "Zydus Cadila receives final approval from USFDA for Liothyronine Sodium Tablets".
Press Release Jan 23 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Jan 04 2021
- Press Release Dec 30 2020
- Press Release Dec 24 2020
- Press Release Dec 09 2020
- Press Release Dec 07 2020
Later from Zydus Lifesciences
- Press Release Jan 25 2021
- Press Release Jan 28 2021
- Press Release Feb 04 2021
- Press Release Feb 05 2021
- Press Release Feb 19 2021
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences